BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 35759211)

  • 1. A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia.
    Correll CU; Agid O; Crespo-Facorro B; de Bartolomeis A; Fagiolini A; Seppälä N; Howes OD
    CNS Drugs; 2022 Jul; 36(7):659-679. PubMed ID: 35759211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: A narrative review and recommendation for clinical practice.
    Agid O; Crespo-Facorro B; de Bartolomeis A; Fagiolini A; Howes OD; Seppälä N; Correll CU
    Eur Neuropsychopharmacol; 2024 Jul; 84():35-47. PubMed ID: 38657339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between the examination rate of treatment-resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study.
    Yasui-Furukori N; Muraoka H; Hasegawa N; Ochi S; Numata S; Hori H; Hishimoto A; Onitsuka T; Ohi K; Hashimoto N; Nagasawa T; Takaesu Y; Inagaki T; Tagata H; Tsuboi T; Kubota C; Furihata R; Iga JI; Iida H; Miura K; Matsumoto J; Yamada H; Watanabe K; Inada K; Shimoda K; Hashimoto R
    Neuropsychopharmacol Rep; 2022 Mar; 42(1):3-9. PubMed ID: 34854260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple serum anti-glutamate receptor antibody levels in clozapine-treated/naïve patients with treatment-resistant schizophrenia.
    He J; Li J; Wei Y; He Z; Liu J; Yuan N; Zhou R; He X; Ren H; Gu L; Liao Y; Chen X; Tang J
    BMC Psychiatry; 2024 Apr; 24(1):248. PubMed ID: 38566016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of Treatment-Resistant and Clozapine-Resistant Schizophrenia: A 12-Year Follow-up Study of First-Episode Schizophrenia-Spectrum Disorders.
    Chan SKW; Chan HYV; Honer WG; Bastiampillai T; Suen YN; Yeung WS; Lam M; Lee WK; Ng RMK; Hui CLM; Chang WC; Lee EHM; Chen EYH
    Schizophr Bull; 2021 Mar; 47(2):485-494. PubMed ID: 33043960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment-Resistant Schizophrenia, Clozapine Resistance, Genetic Associations, and Implications for Precision Psychiatry: A Scoping Review.
    Ying J; Chew QH; McIntyre RS; Sim K
    Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment-Resistant Schizophrenia: Definition, Predictors, and Therapy Options.
    Correll CU; Howes OD
    J Clin Psychiatry; 2021 Sep; 82(5):. PubMed ID: 34496461
    [No Abstract]   [Full Text] [Related]  

  • 8. Feasibility and Effect of Increasing Clozapine Plasma Levels in Long-Stay Patients With Treatment-Resistant Schizophrenia.
    Bogers JPAM; Schulte PFJ; Broekman TG; de Haan L
    J Clin Psychopharmacol; 2023 Mar-Apr 01; 43(2):97-105. PubMed ID: 36825865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient characteristics, burden and pharmacotherapy of treatment-resistant schizophrenia: results from a survey of 204 US psychiatrists.
    Correll CU; Brevig T; Brain C
    BMC Psychiatry; 2019 Nov; 19(1):362. PubMed ID: 31727015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clozapine Treatment Is Associated With Higher Prescription Rate of Antipsychotic Monotherapy and Lower Prescription Rate of Other Concomitant Psychotropics: A Real-World Nationwide Study.
    Ochi S; Tagata H; Hasegawa N; Yasui-Furukori N; Iga JI; Kashiwagi H; Kodaka F; Komatsu H; Tsuboi T; Tokutani A; Numata S; Ichihashi K; Onitsuka T; Muraoka H; Iida H; Ohi K; Atake K; Kishimoto T; Hori H; Takaesu Y; Takeshima M; Usami M; Makinodan M; Hashimoto N; Fujimoto M; Furihata R; Nagasawa T; Yamada H; Matsumoto J; Miura K; Kido M; Hishimoto A; Ueno SI; Watanabe K; Inada K; Hashimoto R
    Int J Neuropsychopharmacol; 2022 Oct; 25(10):818-826. PubMed ID: 35723038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on novel antipsychotics and pharmacological strategies for treatment-resistant schizophrenia.
    de Bartolomeis A; Ciccarelli M; Vellucci L; Fornaro M; Iasevoli F; Barone A
    Expert Opin Pharmacother; 2022 Dec; 23(18):2035-2052. PubMed ID: 36368055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine's multiple cellular mechanisms: What do we know after more than fifty years? A systematic review and critical assessment of translational mechanisms relevant for innovative strategies in treatment-resistant schizophrenia.
    de Bartolomeis A; Vellucci L; Barone A; Manchia M; De Luca V; Iasevoli F; Correll CU
    Pharmacol Ther; 2022 Aug; 236():108236. PubMed ID: 35764175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroimaging findings in treatment-resistant schizophrenia: A systematic review: Lack of neuroimaging correlates of treatment-resistant schizophrenia.
    Nakajima S; Takeuchi H; Plitman E; Fervaha G; Gerretsen P; Caravaggio F; Chung JK; Iwata Y; Remington G; Graff-Guerrero A
    Schizophr Res; 2015 May; 164(1-3):164-75. PubMed ID: 25684554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia.
    Semiz UB; Cetin M; Basoglu C; Ebrinc S; Uzun O; Herken H; Balibey H; Algul A; Ates A
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1330-6. PubMed ID: 17618026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delirium on clozapine: A tale of friend turned foe-A case report.
    Das A; Minner R; Krain L; Spollen J
    Int J Psychiatry Med; 2021 Nov; 56(6):446-458. PubMed ID: 33148081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal changes in clozapine dose in patients with treatment-resistant schizophrenia: a 5-year retrospective cohort study.
    Tsukahara M; So R; Nakajima S; Kitagawa K; Kodama M; Takeuchi H
    Int Clin Psychopharmacol; 2023 Mar; 38(2):96-101. PubMed ID: 36165515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine's critical role in treatment resistant schizophrenia: ensuring both safety and use.
    Remington G; Lee J; Agid O; Takeuchi H; Foussias G; Hahn M; Fervaha G; Burton L; Powell V
    Expert Opin Drug Saf; 2016 Sep; 15(9):1193-203. PubMed ID: 27207070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine and paliperidone palmitate antipsychotic combination in treatment-resistant schizophrenia and other psychotic disorders: A retrospective 6-month mirror-image study.
    Bioque M; Parellada E; García-Rizo C; Amoretti S; Fortea A; Oriolo G; Palau P; Boix-Quintana E; Safont G; Bernardo M
    Eur Psychiatry; 2020 Jul; 63(1):e71. PubMed ID: 32669145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A brief history of clozapine in China with a look forward.
    Ruan CJ; Wang CY; Zang YN; Liu CG; Dong F; Li AN; Wan Z; Guo W; Wang G
    Schizophr Res; 2024 Jun; 268():25-28. PubMed ID: 37236890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine supersensitivity psychosis and delay of clozapine treatment in patients with treatment-resistant schizophrenia.
    Masumo Y; Kanahara N; Kogure M; Yamasaki F; Nakata Y; Iyo M
    Int Clin Psychopharmacol; 2023 Mar; 38(2):102-109. PubMed ID: 36719338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.